ChargePoint Holdings Inc (CHPT)
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-09-14
$8.84-2.43%
Close 2026-09-14 · 1-day change
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-09-14
Research Workspace
Put CHPT beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Quarterly revenue within $90M to $110M guidance range: Q2 rev $116.1M vs $110M target.
View ThesisRevenue is growing steadily — about 9% over the past year.
View GrowthMiddle-of-the-pack management execution.
View ManagementExpectations look high — the market is pricing in about 38% growth a year, above the roughly 11% analysts expect, leaving little room for error.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 63% in its worst 12-month stretch.
View RiskChargePoint's growth depends on achieving revenue targets and improving gross profit margins. Revenue guidance for Q3 FY2027 is set between $105M and $115M, which aligns with growth objectives. It trades at 0.6× price-to-sales versus a peer median of 0.4×, indicating the market prices in more growth than expected. The primary risk is that quarterly revenue fell short of the $110M target, with a 23% probability of missing outlooks. Peer multiples imply a price about 47% below where it trades. This read is provisional.
Trailing returns as of 2026-09-14. CHPT is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 7 analysts currently covering CHPT (as of Sep 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare CHPT with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CHPT Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 1 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Other Specialty Retail — fair value, gap to price, and forward P/E.
Compare the value case
Put CHPT next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Achieve revenue growth within guidance range
Q3 outlook raises concerns about future revenue growth.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Advances: Improve gross profit margins
Record margins directly support improving gross profit margins objective.
Surge indicates potential for revenue growth and market confidence.
Advances: Achieve revenue growth within guidance range
New products and European momentum support revenue growth.
Analyst maintains rating, indicating confidence in growth.
Advances: Achieve revenue growth within guidance range
Revenue guidance aligns with growth objectives.
Advances: Reduce operating losses
Earnings call indicates progress in reducing operating losses.
Advances: Achieve revenue growth within guidance range
Beating revenue estimates supports growth objectives.
